Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical

Unique visitors: 384

Mina T. Kelleni

DOI
https://doi.org/10.1016/j.biopha.2020.110982

Înregistrări online